title: Development of the vault particle as a platform technology.
abstract: Vaults are naturally occurring nanoparticles found widely in eukaryotes. The particles can be produced in large quantities and are assembled in situ from multiple copies of the single structural protein following expression. Using molecular engineering, recombinant vaults can be functionally modified and targeted, and their contents can be controlled by packaging. Here, we review the development of engineered vaults as a platform for a wide variety of therapeutic applications and we examine future directions for this unique nanoparticle system.
authors.affiliation: Department of Biological Chemistry, David Geffen School of Medicine at UCLA, California NanoSystems Institute at UCLA, Los Angeles, California 90095, USA. lrome@mednet.ucla.edu
authors.forename: Leonard H
authors.initials: LH
authors.lastname: Rome
authors.forename: Valerie A
authors.initials: VA
authors.lastname: Kickhoefer
mesh_terms: D000818:Animals; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D036103:Nanotechnology / Q000379:methods*; D015202:Protein Engineering; D014612:Vaccines / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use; D020394:Vault Ribonucleoprotein Particles / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D004337:Drug Carriers; D014612:Vaccines; D020394:Vault Ribonucleoprotein Particles